Your session is about to expire
← Back to Search
Long-Acting Beta Agonist for Asthma (LEARN Trial)
LEARN Trial Summary
This trial compares at-home mobile spirometry to in-clinic spirometry in people with moderate asthma, to measure the effects of LABA treatment on lung function.
- Asthma
LEARN Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LEARN Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have used drugs excessively in the past 6 months, except for medical or non-inhaled marijuana used for fun.You must be using a certain amount of medication for your asthma for at least 6 weeks before the screening.You have had asthma flare-ups or respiratory infections in the past month.You have had a serious infection that needed strong medication to treat within the month before screening.You have asthma that is not well controlled and is causing moderate symptoms.You are currently using other biologic medications to manage your asthma symptoms, except for allergy shots which are allowed.You have been diagnosed with lung diseases like COPD, emphysema, idiopathic pulmonary fibrosis, or other conditions that affect your breathing.
- Group 1: Long-Acting Beta Agonist
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are adults aged 20 or older suitable candidates for this medical trial?
"The lowest permissible age for inclusion in this trial is 18, while the upper bound of eligibility caps at 65 years old."
Are there still opportunities to enroll in this research endeavor?
"As seen on clinicaltrials.gov, this research is currently searching for participants. The trial was announced on April 21st 2023 and last modified on June 1st of the same year."
Are numerous medical centers facilitating this experiment in the metropolitan area?
"Patients for this trial can be found through 9 recruiting sites. These include, but are not limited to, El Paso Pulmonary Association in El Paso, Northeast Medical Research Associates Inc. in North Dartmouth and AllerVie Research Clinic in Columbus."
What is the enrollment size of this clinical trial?
"To satisfy the clinical trial's requirements, Koneksa Health is recruiting 60 qualified patients from two sites: El Paso Pulmonary Association in El Paso, Massachusetts and Northeast Medical Research Associates, Inc. in North Dartmouth, Georgia."
What objectives are researchers hoping to accomplish through this investigation?
"The primary focus of the trial, assessed over a 43-day period from Baseline Day 1 to End of Study Day 43, is Measured FEV1 Change in Response to Treatment. Secondary outcome measures include Time Taken for Treatment Effect Detection via Changes in Home Spirometry Measurement (FEV1), Mobile Spirometry Modifications and their Relationship with ACQ-6 Variations, as well as Correlations Between In-Clinic and mSpirometry Parameters such FVC and FET."
Does my health history and profile qualify me for enrollment in this experiment?
"To be eligible for this research trial, patients must possess a diagnosis of asthma and fall between two age thresholds (18 to 65 years old). Overall, 60 participants are required."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger